Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew Snats (SNN)
:SNN
SNN Stock Chart & Stats
$36.53
-$0.18(-0.73%)
At close: 4:00 PM EST
$36.53
-$0.18(-0.73%)
Day’s Range― - ―
52-Week Range$23.69 - $38.79
Previous CloseN/A
Volume262.39K
Average Volume (3M)620.93K
Market Cap
$13.94B
Enterprise Value$16.07B
Total Cash (Recent Filing)$675.41M
Total Debt (Recent Filing)$3.45B
Price to Earnings (P/E)29.2
Beta0.54
Next Earnings
Mar 02, 2026EPS Estimate
1.15Last Dividend Ex-Date
Oct 03, 2025Dividend Yield2.23%
Share Statistics
EPS (TTM)0.86
Shares Outstanding424,862,000
10 Day Avg. Volume506,157
30 Day Avg. Volume620,933
Financial Highlights & Ratios
PEG Ratio-1.21
Price to Book (P/B)2.05
Price to Sales (P/S)1.85
P/FCF Ratio17.78
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue2.69
Enterprise Value/Gross Profit3.84
Enterprise Value/Ebitda11.16
Forecast
1Y Price Target
$36.05Price Target Upside-1.31% Downside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial GuidanceThe company raised its free cash flow guidance to approximately $750 million, reflecting strong performance and continued capital improvements, particularly in orthopedics.
Operational EfficiencySmith & Nephew Snats reiterated its expectations to deliver 5% underlying growth and expects a stronger trading profit margin as it works to deliver on operational savings.
Shareholder ReturnsSmith & Nephew Snats completed its $500 million share buyback, which was announced in the previous quarter.
Bears Say
Geopolitical And Tariff ImpactsSNN continues to expect a $15–$20 million 2025 headwind due to potential US tariff impacts, with impacts compounding further in 2026.
Market ChallengesSNN delivered a mixed quarter, modestly beating top-line expectations but coming in below consensus, with underlying growth of +5% in what was a challenging quarter for US knee performance.
Price Target AdjustmentThe price target for Smith & Nephew Snats was slightly lowered to $34 to align with the current share price and account for a 25% discount to the large cap MedTech comparison group median.
Smith & Nephew Snats News
SNN FAQ
What was Smith & Nephew Snats’s price range in the past 12 months?
Smith & Nephew Snats lowest stock price was $23.69 and its highest was $38.79 in the past 12 months.
What is Smith & Nephew Snats’s market cap?
Smith & Nephew Snats’s market cap is $13.94B.
When is Smith & Nephew Snats’s upcoming earnings report date?
Smith & Nephew Snats’s upcoming earnings report date is Mar 02, 2026 which is in 84 days.
How were Smith & Nephew Snats’s earnings last quarter?
Smith & Nephew Snats released its earnings results on Aug 05, 2025. The company reported $0.858 earnings per share for the quarter, the consensus estimate of $0.858 by $0.
Is Smith & Nephew Snats overvalued?
According to Wall Street analysts Smith & Nephew Snats’s price is currently Overvalued.
Does Smith & Nephew Snats pay dividends?
Smith & Nephew Snats pays a Semiannually dividend of $0.285 which represents an annual dividend yield of 2.23%. See more information on Smith & Nephew Snats dividends here
What is Smith & Nephew Snats’s EPS estimate?
Smith & Nephew Snats’s EPS estimate is 1.15.
How many shares outstanding does Smith & Nephew Snats have?
Smith & Nephew Snats has 424,862,000 shares outstanding.
What happened to Smith & Nephew Snats’s price movement after its last earnings report?
Smith & Nephew Snats reported an EPS of $0.858 in its last earnings report, expectations of $0.858. Following the earnings report the stock price went up 15.221%.
Which hedge fund is a major shareholder of Smith & Nephew Snats?
Currently, no hedge funds are holding shares in SNN
Smith & Nephew Snats Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$36.05 (-1.31% Downside)
$36.05 (-1.31% Downside)
Blogger Sentiment
Bullish
SNN Sentiment 70%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 309.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.96%
12-Months-Change
Fundamentals
Return on Equity
9.20%
Trailing 12-Months
Asset Growth
1.33%
Trailing 12-Months
Company Description
Smith & Nephew Snats
Smith & Nephew Snats (SNN) is a global medical technology company specializing in advanced wound management, orthopedic reconstruction, and sports medicine. The company operates in three main sectors: Advanced Wound Management, Orthopedics, and Sports Medicine. SNN offers a range of products including wound care dressings, surgical instruments, implants for hip and knee replacements, and minimally invasive surgical solutions for various orthopedic procedures.
SNN Company Deck
SNN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Smith & Nephew reported strong revenue growth, profitability improvements, and significant cash flow increases, along with a major share buyback announcement. However, challenges remain, particularly in emerging markets, and potential headwinds from U.S. tariffs and reimbursement changes. Overall, the company appears optimistic about sustaining growth and improving margins.View all SNN earnings summariesSNN Stock 12 Month Forecast
Average Price Target
$36.05
▼(-1.31% Downside)
Technical Analysis
Boston Scientific
―
Edwards Lifesciences
―
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
―
Insiders
0.38% Mutual Funds
2.95% Other Institutional Investors
96.48% Public Companies and
Individual Investors